Clinical Review

Regular review

Treatment of Helicobacter pylori infection

BMJ 2000; 320 doi: 10.1136/bmj.320.7226.31 (Published 1 January 2000)
Cite this as: BMJ 2000;320:31

Access to the full text of this article requires a subscription or payment. Please log in or subscribe below.

  1. Wink A de Boer, internista,
  2. Guido N J Tytgat, professorb
  1. aDepartment of Internal Medicine, Sint Anna Hospital, Postbus 10, 5340 BE Oss, Netherlands
  2. bDepartment of Gastroenterology and Hepatology, Academic Medical Centre, Amsterdam, Netherlands
  1. Correspondence to: W A de Boer

    The bacterium Helicobacter pylori can infect the stomach during childhood and cause lifelong chronic gastritis, which can lead to peptic ulcer disease. Curing H pylori infection cures ulcer disease.1–5 And since reinfection in adults is extremely rare,6 adequate treatment permanently cures this former chronic recurrent, serious disease. If ulcers do not recur neither do ulcer perforation or bleeding; quality of life increases,7 sick leave decreases, and less money is spent on visiting the doctor and drugs.

    Antibiotic resistance needs to be taken into account when designing treatment for H pylori infection.8 Over the past decade many different therapies were promoted and recommendations changed rapidly. Most doctors lost track, and a great variety of treatments is being used.9 In this article we will try to provide a basic framework on which treatment can be based.

    Summary points

    The therapeutic goal is to cure H pylori infection in all ulcer patients

    Several equally effective regimens are available, but even the best fail in 5-20% of patients

    Antibiotic resistance is usually induced after failure, and initial regimens should not compromise future therapeutic possibilities

    Doctors should choose two complementary regimens, which if used consecutively come close to 100% cure

    Treatment should start with a regimen based on clarithromycin with a back up regimen based on metronidazole unless resistance is above 15%, in which case the order should be reversed

    Triple regimens which combine clarithromycin and metronidazole should not be used as there is no valid empirical back up regimen after failure

    Methods

    This article is based largely on our experience in treating H pyloriinfection. We base our recommendations on basic bacteriological principles and on a regularly updated in-house computer database that contains the results of all published therapeutic studies.

    Who should be treated?

    Treatment to eradicate H pylori in patients with a proved …

    Access to the full text of this article requires a subscription or payment

    Subscribe

    Article access

    Article access for 1 day

    Purchase this article for £20 $30 €32*

    The PDF version can be downloaded as your personal record

    * Prices do not include VAT

    Rapid responses

    THIS WEEK'S POLL

    BMJ most popular